Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

Autor: Berger, Stefan P., Sommerer, Claudia, Witzke, Oliver, Tedesco, Helio, Chadban, Steve, Mulgaonkar, Shamkant, Qazi, Yasir, de Fijter, Johan W., Oppenheimer, Federico, Cruzado, Josep M., Watarai, Yoshihiko, Massari, Pablo, Legendre, Christophe, Citterio, Franco, Henry, Mitchell, Srinivas, Titte R., Vincenti, Flavio, Gutierrez, Maria Pilar Hernandez, Marti, Ana Maria, Bernhardt, Peter, Pascual, Julio *
Zdroj: In American Journal of Transplantation November 2019 19(11):3018-3034
Databáze: ScienceDirect
Externí odkaz: